 MINNEAPOLIS, MN ACCESSWIRE December 2, 2021 Celcuity Inc. NASDAQ:CELC, a clinical-stage biotechnology company pursuing an integrated therapeutic and companion diagnostic strategy for treating patients with cancer, today announced that an abstract has been accepted for poster presentation at the 2021 San Antonio Breast Cancer Symposium SABCS, which is being held virtually and in-person from December 7-10, 2021. Poster presentation details are provided below. 